Hematology/Oncology

Top Story

VIDEO: First-line venetoclax-ibrutinib ‘a win on all fronts’ in CLL

December 10, 2019
Meeting NewsVideo

VIDEO: Blinatumomab has potential to become ‘new standard of care’ as post-reinduction therapy for pediatric B-ALL

December 10, 2019
ORLANDO — In this video, Ryan D. Cassaday, MD, attending physician at the Seattle Cancer Care Alliance, associate professor of medicine at the University of…
Meeting News

Low-cost assay may improve lymphoma diagnostics in lower income countries

December 10, 2019
ORLANDO — A low-cost gene expression assay using FFPE biopsies can classify multiple lymphoma subtypes as well as non-lymphoma diagnoses with high accuracy in a…
Meeting NewsVideo

Polatuzumab vedotin plus obinutuzumab, lenalidomide shows promise in R/R follicular lymphoma

December 10, 2019
ORLANDO — Catherine Diefenbach, MD, director of the clinical lymphoma program and of hematology translational research, Perlmutter Cancer Center at NYU Langone…
Meeting News

Hemophilia B clinically less severe than A, though with similar QOL

December 10, 2019
ORLANDO – Despite clinical evidence that hemophilia B presents with less severity on a clinical level than hemophilia A, patients report similar quality of life…
More Headlines »
CME

Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago

This activity is supported by an educational grant from Biotheranostics, Inc.

Multigene assays that evaluate an array of prognostic and/or predictive molecular markers have become critical for the…
More »
Video
Meeting News

VIDEO: Eisai executive highlights thyroid cancer data, company pipeline

July 20, 2019
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision-making – Rapid Response From Amsterdam

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next